Structural basis of Cas3 inhibition by the bacteriophage protein AcrF3

Xiaofei Wang,Deqiang Yao,Jin-Gen Xu,A-Rong Li,Jianpo Xu,Panhan Fu,Yan Zhou,Yongqun Zhu

DOI: https://doi.org/10.1038/nsmb.3269

2016-01-01

Nature Structural & Molecular Biology

Abstract:The crystal structure of the phage anti-CRISPR protein AcrF3 in complex with Cas3 reveals its mode of inhibition of the CRISPR–Cas bacterial immune system.

What problem does this paper attempt to address?

Mechanistic insights into the inhibition of the CRISPR-Cas surveillance complex by anti-CRISPR protein AcrIF13

Hao Wang,Teng Gao,Yu Zhou,Junhui Ren,Junhua Guo,Jianwei Zeng,Yu Xiao,Yi Zhang,Yue Feng

DOI: https://doi.org/10.1016/j.jbc.2022.101636

IF: 5.485

2022-03-01

Journal of Biological Chemistry

Abstract:Clustered regularly interspaced short palindromic repeats (CRISPRs) and CRISPR-associated (Cas) proteins provide prokaryotes with nucleic acid-based adaptive immunity against infections of mobile genetic elements, including phages. To counteract this immune process, phages have evolved various anti-CRISPR (Acr) proteins which deactivate CRISPR-Cas-based immunity. However, the mechanisms of many of these Acr-mediated inhibitions are not clear. Here, we report the crystal structure of AcrIF13 and explore its inhibition mechanism. The structure of AcrIF13 is unique and displays a negatively charged surface. Additionally, biochemical studies identified that AcrIF13 interacts with the type I-F CRISPR-Cas surveillance complex (Csy complex) to block target DNA recognition and that the Cas5f-8f tail and Cas7.6f subunit of the Csy complex are specific binding targets of AcrIF13. Further mutational studies demonstrated that several negatively charged residues of AcrIF13 and positively charged residues of Cas8f and Cas7f of the Csy complex are involved in AcrIF13-Csy binding. Together, our findings provide mechanistic insights into the inhibition mechanism of AcrIF13 and further suggest the prevalence of the function of Acr proteins as DNA mimics.

biochemistry & molecular biology
Structural and biochemical insights into the mechanism of the anti-CRISPR protein AcrIE3

Jasung Koo,Gyujin Lee,Changkon Park,Hyejin Oh,Sung-Hyun Hong,Jeong-Yong Suh,Euiyoung Bae

DOI: https://doi.org/10.1016/j.str.2024.10.024

IF: 5.871

2024-11-20

Structure

Abstract:Summary Anti-CRISPR (Acr) proteins are natural inhibitors of CRISPR-Cas systems, found in bacteriophages and other genetic elements. AcrIE3, identified in a Pseudomonas phage, inactivates the type I-E CRISPR-Cas system in Pseudomonas aeruginosa by engaging with the Cascade complex. However, its precise inhibition mechanism has remained elusive. In this study, we present a comprehensive structural and biochemical analysis of AcrIE3, providing mechanistic insight into its anti-CRISPR function. Our results reveal that AcrIE3 selectively binds to the Cas8e subunit of the Cascade complex. The crystal structure of AcrIE3 exhibits an all-helical fold with a negatively charged surface. Through extensive mutational analyses, we show that AcrIE3 interacts with the protospacer adjacent motif (PAM) recognition site in Cas8e through its negatively charged surface residues. These findings enhance our understanding of the structure and function of type I-E Acr proteins, suggesting PAM interaction sites as primary targets for divergent Acr inhibitors.

cell biology,biochemistry & molecular biology,biophysics
Structural and Mechanistic Insight into CRISPR-Cas9 Inhibition by Anti-CRISPR Protein AcrIIC4Hpa

Sungwon Hwang,Chuxi Pan,Bianca Garcia,Alan R Davidson,Trevor F Moraes,Karen L Maxwell

DOI: https://doi.org/10.1016/j.jmb.2021.167420

2022-03-15

Abstract:Phages, plasmids, and other mobile genetic elements express inhibitors of CRISPR-Cas immune systems, known as anti-CRISPR proteins, to protect themselves from targeted destruction. These anti-CRISPR proteins have been shown to function through very diverse mechanisms. In this work we investigate the activity of an anti-CRISPR isolated from a prophage in Haemophilus parainfluenzae that blocks CRISPR-Cas9 DNA cleavage activity. We determine the three-dimensional crystal structure of AcrIIC4Hpa and show that it binds to the Cas9 Recognition Domain. This binding does not prevent the Cas9-anti-CRISPR complex from interacting with target DNA but does inhibit DNA cleavage. AcrIIC4Hpa likely acts by blocking the conformational changes that allow the HNH and RuvC endonuclease domains to contact the DNA sites to be nicked.
Mechanism of inhibition of CRISPR-Cas9 by anti-CRISPR protein AcrIIC1

Yalan Zhu,Sen Yin,Zhao Li

DOI: https://doi.org/10.1016/j.bbrc.2023.02.065

2023-04-30

Abstract:CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR associated) systems are bacterial and archaeal defense mechanisms against invading phages and viruses. To overcome these defenses, phages and other mobile genetic elements (MGEs) have evolved multiple anti-CRISPR proteins (Acrs) that can inhibit the function of CRISPR-Cas systems. The AcrIIC1 protein has been shown to be able to inhibit the activity of Neisseria meningitidis Cas9 (NmeCas9) in both bacteria and human cells. Here, we solve the structure of AcrIIC1 in complex with the HNH domain of NmeCas9 using X-ray crystallography. The structure shows that AcrIIC1 binds to the catalytic sites of the HNH domain, preventing it from accessing the DNA target. In addition, our biochemical data show that AcrIIC1 is a broad-spectrum inhibitor targeting Cas9 enzymes from different subtypes. Taken together, the structure and biochemical analysis reveal the molecular mechanism of AcrIIC1-mediated Cas9 inhibition and provide new insights into regulatory tools for Cas9-based applications.
Structural and mechanistic insights into inhibition of the type I-F CRISPR-Cas surveillance complex by AcrIF4

Zhengyu Gao,Laixing Zhang,Zihao Ge,Hao Wang,Yourun Yue,Zhuobing Jiang,Xin Wang,Chenying Xu,Yi Zhang,Maojun Yang,Yue Feng

DOI: https://doi.org/10.1101/2022.08.30.504949

2022-01-01

Abstract:CRISPR-Cas system provides prokaryotes with protection against mobile genetic elements (MGEs) such as phages. In turn, phages deploy anti-CRISPR (Acr) proteins to evade this immunity. AcrIF4, an Acr targeting the type I-F CRISPR-Cas system, has been reported to bind the crRNA-guided surveillance (Csy) complex. However, it remains controversial whether AcrIF4 inhibits target DNA binding to the Csy complex. Here, we present structural and mechanistic studies into AcrIF4, exploring its unique anti-CRISPR mechanism. While the Csy-AcrIF4 complex displays decreased affinity for target DNA, it is still able to bind the DNA. Structural and functional analyses of the Csy-AcrIF4-dsDNA complex revealed that AcrIF4 binding prevents rotation of the helical bundle (HB) of Cas8f induced by dsDNA binding, therefore resulting in failure of Cas2/3 recruitment and DNA cleavage. Overall, our study provides an interesting example of attack on the nuclease recruitment event by an Acr, but not conventional mechanisms of blocking binding of target DNA. ### Competing Interest Statement The authors have declared no competing interest.
Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2

Annoj Thavalingam,Zhi Cheng,Bianca Garcia,Xue Huang,Megha Shah,Wei Sun,Min Wang,Lucas Harrington,Sungwon Hwang,Yurima Hidalgo-Reyes,Erik J Sontheimer,Jennifer Doudna,Alan R Davidson,Trevor F Moraes,Yanli Wang,Karen L Maxwell

DOI: https://doi.org/10.1038/s41467-019-10577-3

2019-06-26

Abstract:CRISPR-Cas adaptive immune systems function to protect bacteria from invasion by foreign genetic elements. The CRISPR-Cas9 system has been widely adopted as a powerful genome-editing tool, and phage-encoded inhibitors, known as anti-CRISPRs, offer a means of regulating its activity. Here, we report the crystal structures of anti-CRISPR protein AcrIIC2Nme alone and in complex with Nme1Cas9. We demonstrate that AcrIIC2Nme inhibits Cas9 through interactions with the positively charged bridge helix, thereby preventing sgRNA loading. In vivo phage plaque assays and in vitro DNA cleavage assays show that AcrIIC2Nme mediates its activity through a large electronegative surface. This work shows that anti-CRISPR activity can be mediated through the inhibition of Cas9 complex assembly.
Inhibitory mechanism of CRISPR-Cas9 by AcrIIC4

Xuzichao Li,Fumeng Liao,Jiaqi Gao,Guangyong Song,Chendi Zhang,Nan Ji,Xiaoshen Wang,Jing Wen,Jia He,Yong Wei,Heng Zhang,Zhuang Li,Guimei Yu,Hang Yin

DOI: https://doi.org/10.1093/nar/gkad669

IF: 14.9

2023-08-18

Nucleic Acids Research

Abstract:CRISPR-Cas systems act as the adaptive immune systems of bacteria and archaea, targeting and destroying invading foreign mobile genetic elements (MGEs) such as phages. MGEs have also evolved anti-CRISPR (Acr) proteins to inactivate the CRISPR-Cas systems. Recently, AcrIIC4, identified from Haemophilus parainfluenzae phage, has been reported to inhibit the endonuclease activity of Cas9 from Neisseria meningitidis (NmeCas9), but the inhibition mechanism is not clear. Here, we biochemically and structurally investigated the anti-CRISPR activity of AcrIIC4. AcrIIC4 folds into a helix bundle composed of three helices, which associates with the REC lobe of NmeCas9 and sgRNA. The REC2 domain of NmeCas9 is locked by AcrIIC4, perturbing the conformational dynamics required for the target DNA binding and cleavage. Furthermore, mutation of the key residues in the AcrIIC4-NmeCas9 and AcrIIC4-sgRNA interfaces largely abolishes the inhibitory effects of AcrIIC4. Our study offers new insights into the mechanism of AcrIIC4-mediated suppression of NmeCas9 and provides guidelines for the design of regulatory tools for Cas9-based gene editing applications.

biochemistry & molecular biology
AcrIIC4 inhibits type II-C Cas9 by preventing R-loop formation

Wei Sun,Zhi Cheng,Jiuyu Wang,Jing Yang,Xueyan Li,Jinlong Wang,Minxuan Chen,Xiaoqi Yang,Gang Sheng,Jizhong Lou,Yanli Wang

DOI: https://doi.org/10.1073/pnas.2303675120

Abstract:Anti-CRISPR (Acr) proteins are encoded by phages and other mobile genetic elements and inhibit host CRISPR-Cas immunity using versatile strategies. AcrIIC4 is a broad-spectrum Acr that inhibits the type II-C CRISPR-Cas9 system in several species by an unknown mechanism. Here, we determined a series of structures of Haemophilus parainfluenzae Cas9 (HpaCas9)-sgRNA in complex with AcrIIC4 and/or target DNA, as well as the crystal structure of AcrIIC4 alone. We found that AcrIIC4 resides in the crevice between the REC1 and REC2 domains of HpaCas9, where its extensive interactions restrict the mobility of the REC2 domain and prevent the unwinding of target double-stranded (ds) DNA at the PAM-distal end. Therefore, the full-length guide RNA:target DNA heteroduplex fails to form in the presence of AcrIIC4, preventing Cas9 nuclease activation. Altogether, our structural and biochemical studies illuminate a unique Acr mechanism that allows DNA binding to the Cas9 effector complex but blocks its cleavage by preventing R-loop formation, a key step supporting DNA cleavage by Cas9.
Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein

De Dong,Minghui Guo,Sihan Wang,Yuwei Zhu,Shuo Wang,Zhi Xiong,Jianzheng Yang,Zengliang Xu,Zhiwei Huang

DOI: https://doi.org/10.1038/nature22377

IF: 64.8

2017-06-15

Nature

Abstract:CRISPR-Cas9 systems are bacterial adaptive immune systems that defend against infection by phages. Through the RNA-guided endonuclease activity of Cas9 they degrade double-stranded DNA with a protospacer adjacent motif (PAM) and sequences complementary to the guide RNA. Recently, two anti-CRISPR proteins (AcrIIA2 and AcrIIA4 from Listeria monocytogenes prophages) were identified, both of which inhibit Streptococcus pyogenes Cas9 (SpyCas9) and L. monocytogenes Cas9 activity in bacteria and human cells. However, the mechanism of AcrIIA2- or AcrIIA4-mediated Cas9 inhibition remains unknown. Here we report a crystal structure of SpyCas9 in complex with a single-guide RNA (sgRNA) and AcrIIA4. Our data show that AcrIIA2 and AcrIIA4 interact with SpyCas9 in a sgRNA-dependent manner. The structure reveals that AcrIIA4 inhibits SpyCas9 activity by structurally mimicking the PAM to occupy the PAM-interacting site in the PAM-interacting domain, thereby blocking recognition of double-stranded DNA substrates by SpyCas9. AcrIIA4 further inhibits the endonuclease activity of SpyCas9 by shielding its RuvC active site. Structural comparison reveals that formation of the AcrIIA4-binding site of SpyCas9 is induced by sgRNA binding. Our study reveals the mechanism of SpyCas9 inhibition by AcrIIA4, providing a structural basis for developing 'off-switch' tools for SpyCas9 to avoid unwanted genome edits within cells and tissues.
Structural basis for inhibition of an archaeal CRISPR–Cas type I-D large subunit by an anti-CRISPR protein

M. Cemre Manav,Lan B. Van,Jinzhong Lin,Anders Fuglsang,Xu Peng,Ditlev E. Brodersen

DOI: https://doi.org/10.1038/s41467-020-19847-x

IF: 16.6

2020-11-25

Nature Communications

Abstract:Abstract A hallmark of type I CRISPR–Cas systems is the presence of Cas3, which contains both the nuclease and helicase activities required for DNA cleavage during interference. In subtype I-D systems, however, the histidine-aspartate (HD) nuclease domain is encoded as part of a Cas10-like large effector complex subunit and the helicase activity in a separate Cas3’ subunit, but the functional and mechanistic consequences of this organisation are not currently understood. Here we show that the Sulfolobus islandicus type I-D Cas10d large subunit exhibits an unusual domain architecture consisting of a Cas3-like HD nuclease domain fused to a degenerate polymerase fold and a C-terminal domain structurally similar to Cas11. Crystal structures of Cas10d both in isolation and bound to S. islandicus rod-shaped virus 3 AcrID1 reveal that the anti-CRISPR protein sequesters the large subunit in a non-functional state unable to form a cleavage-competent effector complex. The architecture of Cas10d suggests that the type I-D effector complex is similar to those found in type III CRISPR–Cas systems and that this feature is specifically exploited by phages for anti-CRISPR defence.

multidisciplinary sciences
Structural Basis for AcrVA4 Inhibition of Specific CRISPR-Cas12a

Gavin J. Knott,Brady F. Cress,Jun-Jie Liu,Brittney W. Thornton,Rachel J. Lew,Basem Al-Shayeb,Daniel J. Rosenberg,Michel Hammel,Benjamin A. Adler,Marco J. Lobba,Michael Xu,Adam P. Arkin,Christof Fellmann,Jennifer A. Doudna

DOI: https://doi.org/10.7554/elife.49110

IF: 7.7

2019-01-01

eLife

Abstract:CRISPR-Cas systems provide bacteria and archaea with programmable immunity against mobile genetic elements. Evolutionary pressure by CRISPR-Cas has driven bacteriophage to evolve small protein inhibitors, anti-CRISPRs (Acrs), that block Cas enzyme function by wide-ranging mechanisms. We show here that the inhibitor AcrVA4 uses a previously undescribed strategy to recognize the L. bacterium Cas12a (LbCas12a) pre-crRNA processing nuclease, forming a Cas12a dimer, and allosterically inhibiting DNA binding. The Ac. species Cas12a (AsCas12a) enzyme, widely used for genome editing applications, contains an ancestral helical bundle that blocks AcrVA4 binding and allows it to escape anti-CRISPR recognition. Using biochemical, microbiological, and human cell editing experiments, we show that Cas12a orthologs can be rendered either sensitive or resistant to AcrVA4 through rational structural engineering informed by evolution. Together, these findings explain a new mode of CRISPR-Cas inhibition and illustrate how structural variability in Cas effectors can drive opportunistic co-evolution of inhibitors by bacteriophage.
Anti-CRISPR Protein AcrIF4 Inhibits the Type I-F CRISPR-Cas Surveillance Complex by Blocking Nuclease Recruitment and DNA Cleavage

Zhengyu Gao,Laixing Zhang,Zihao Ge,Hao Wang,Yourun Yue,Zhuobing Jiang,Xin Wang,Chenying Xu,Yi Zhang,Maojun Yang,Yue Feng

DOI: https://doi.org/10.1016/j.jbc.2022.102575

IF: 5.485

2022-01-01

Journal of Biological Chemistry

Abstract:The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas system provides prokaryotes with protection against mobile genetic elements such as phages. In turn, phages deploy anti-CRISPR (Acr) proteins to evade this immunity. AcrIF4, an Acr targeting the type I-F CRISPR-Cas system, has been reported to bind the crRNA-guided surveillance (Csy) complex. However, it remains controversial whether AcrIF4 inhibits target DNA binding to the Csy complex. Here, we present structural and mechanistic studies into AcrIF4, exploring its unique anti-CRISPR mechanism. While the Csy-AcrIF4 complex displays decreased affinity for target DNA, it is still able to bind the DNA. Our structural and functional analyses of the Csy-AcrIF4-dsDNA complex revealed that AcrIF4 binding prevents rotation of the helical bundle of the Cas8f subunit induced by dsDNA binding, therefore resulting in failure of nuclease Cas2/3 recruitment and DNA cleavage. Overall, our study provides an interesting example of attack on the nuclease recruitment event by an Acr, but not conventional mechanisms of blocking binding of target DNA.
Cas9 Allosteric Inhibition by the Anti-CRISPR Protein AcrIIA6

Olivier Fuchsbauer,Paolo Swuec,Claire Zimberger,Béatrice Amigues,Sébastien Levesque,Daniel Agudelo,Alexis Duringer,Antonio Chaves-Sanjuan,Silvia Spinelli,Geneviève M Rousseau,Minja Velimirovic,Martino Bolognesi,Alain Roussel,Christian Cambillau,Sylvain Moineau,Yannick Doyon,Adeline Goulet

DOI: https://doi.org/10.1016/j.molcel.2019.09.012

2019-12-19

Abstract:In the arms race against bacteria, bacteriophages have evolved diverse anti-CRISPR proteins (Acrs) that block CRISPR-Cas immunity. Acrs play key roles in the molecular coevolution of bacteria with their predators, use a variety of mechanisms of action, and provide tools to regulate Cas-based genome manipulation. Here, we present structural and functional analyses of AcrIIA6, an Acr from virulent phages, exploring its unique anti-CRISPR action. Our cryo-EM structures and functional data of AcrIIA6 binding to Streptococcus thermophilus Cas9 (St1Cas9) show that AcrIIA6 acts as an allosteric inhibitor and induces St1Cas9 dimerization. AcrIIA6 reduces St1Cas9 binding affinity for DNA and prevents DNA binding within cells. The PAM and AcrIIA6 recognition sites are structurally close and allosterically linked. Mechanistically, AcrIIA6 affects the St1Cas9 conformational dynamics associated with PAM binding. Finally, we identify a natural St1Cas9 variant resistant to AcrIIA6 illustrating Acr-driven mutational escape and molecular diversification of Cas9 proteins.
Insights into the inhibition of type I-F CRISPR-Cas system by a multifunctional anti-CRISPR protein AcrIF24

Lingguang Yang,Laixing Zhang,Peipei Yin,Hao Ding,Yu Xiao,Jianwei Zeng,Wenhe Wang,Huan Zhou,Qisheng Wang,Yi Zhang,Zeliang Chen,Maojun Yang,Yue Feng

DOI: https://doi.org/10.1038/s41467-022-29581-1

IF: 16.6

2022-04-11

Nature Communications

Abstract:Abstract CRISPR-Cas systems are prokaryotic adaptive immune systems and phages use anti-CRISPR proteins (Acrs) to counteract these systems. Here, we report the structures of AcrIF24 and its complex with the crRNA-guided surveillance (Csy) complex. The HTH motif of AcrIF24 can bind the Acr promoter region and repress its transcription, suggesting its role as an Aca gene in self-regulation. AcrIF24 forms a homodimer and further induces dimerization of the Csy complex. Apart from blocking the hybridization of target DNA to the crRNA, AcrIF24 also induces the binding of non-sequence-specific dsDNA to the Csy complex, similar to AcrIF9, although this binding seems to play a minor role in AcrIF24 inhibitory capacity. Further structural and biochemical studies of the Csy-AcrIF24-dsDNA complexes and of AcrIF24 mutants reveal that the HTH motif of AcrIF24 and the PAM recognition loop of the Csy complex are structural elements essential for this non-specific dsDNA binding. Moreover, AcrIF24 and AcrIF9 display distinct characteristics in inducing non-specific DNA binding. Together, our findings highlight a multifunctional Acr and suggest potential wide distribution of Acr-induced non-specific DNA binding.

multidisciplinary sciences
Insights into the Dual Functions of AcrIF14 During the Inhibition of Type I-F CRISPR–Cas Surveillance Complex

Xi Liu,Laixing Zhang,Yu Xiu,Teng Gao,Ling Huang,Yongchao Xie,Lingguang Yang,Wenhe Wang,Peiyi Wang,Yi Zhang,Maojun Yang,Yue Feng

DOI: https://doi.org/10.1093/nar/gkab738

IF: 14.9

2021-01-01

Nucleic Acids Research

Abstract:CRISPR-Cas systems are bacterial adaptive immune systems, and phages counteract these systems using many approaches such as producing anti-CRISPR (Acr) proteins. Here, we report the structures of both AcrIF14 and its complex with the crRNA-guided surveillance (Csy) complex. Our study demonstrates that apart from interacting with the Csy complex to block the hybridization of target DNA to the crRNA, AcrIF14 also endows the Csy complex with the ability to interact with non-sequence-specific dsDNA as AcrIF9 does. Further structural studies of the Csy-AcrIF14-dsDNA complex and biochemical studies uncover that the PAM recognition loop of the Cas8f subunit of the Csy complex and electropositive patches within the N-terminal domain of AcrIF14 are essential for the non-sequence-specific dsDNA binding to the Csy-AcrIF14 complex, which is different from the mechanism of AcrIF9. Our findings highlight the prevalence of Acr-induced non-specific DNA binding and shed light on future studies into the mechanisms of such Acr proteins.
Alternate binding modes of anti-CRISPR viral suppressors AcrF1/2 to Csy surveillance complex revealed by cryo-EM structures

Ruchao Peng,Ying Xu,Tengfei Zhu,Ningning Li,Jianxun Qi,Yan Chai,Min Wu,Xinzheng Zhang,Yi Shi,Peiyi Wang,Jiawei Wang,Ning Gao,George Fu Gao

DOI: https://doi.org/10.1038/cr.2017.79

IF: 44.1

2017-01-01

Cell Research

Abstract:Bacteriophages encode anti-CRISPR suppressors to counteract the CRISPR/Cas immunity of their bacterial hosts, thus facilitating their survival and replication. Previous studies have shown that two phage-encoded anti-CRISPR proteins, AcrF1 and AcrF2, suppress the type I-F CRISPR/Cas system of Pseudomonas aeruginosa by preventing target DNA recognition by the Csy surveillance complex, but the precise underlying mechanism was unknown. Here we present the structure of AcrF1/2 bound to the Csy complex determined by cryo-EM single-particle reconstruction. By structural analysis, we found that AcrF1 inhibits target DNA recognition of the Csy complex by interfering with base pairing between the DNA target strand and crRNA spacer. In addition, multiple copies of AcrF1 bind to the Csy complex with different modes when working individually or cooperating with AcrF2, which might exclude target DNA binding through different mechanisms. Together with previous reports, we provide a comprehensive working scenario for the two anti-CRISPR suppressors, AcrF1 and AcrF2, which silence CRISPR/Cas immunity by targeting the Csy surveillance complex.
Structural insight into multistage inhibition of CRISPR-Cas12a by AcrVA4

Ruchao Peng,Zhiteng Li,Ying Xu,Shaoshuai He,Qi Peng,Lian-Ao Wu,Ying Wu,Jianxun Qi,Peiyi Wang,Yi Shi,George F Gao,Lian-ao Wu,George F. Gao

DOI: https://doi.org/10.1073/pnas.1909400116

IF: 11.1

2019-08-29

Proceedings of the National Academy of Sciences

Abstract:Significance Bacteriophage encodes anti-CRISPR (Acr) proteins to inactivate host bacterial CRISPR-Cas systems. These Acrs are also found in bacteria to avoid self-targeting autoimmunity. So far, quite a few Acrs targeting type I and II CRISPR-Cas systems have been well characterized. In contrast, the Acrs inhibiting type V systems remain poorly understood. Both type II (Cas9) and V (Cas12a) CRISPR-Cas systems have been harnessed as powerful tools for genome editing and the latter showed even better efficiency and accuracy. In this work, we report a comprehensive mechanistic insight into a unique multistage inhibitor, AcrVA4, blocking CRISPR-Cas12a activity, different from other characterized single-stage targeting Acrs. This represents a sophisticated mechanism for CRISPR-Cas inhibition and provides clues for developing regulatory tools for genome editing.

multidisciplinary sciences
Molecular Basis for Inhibition of Type Iii-B Crispr-Cas by an Archaeal Viral Anti-Crispr Protein

Jinzhong Lin,Lauge Alfastsen,Yuvaraj Bhoobalan-Chitty,Xu Peng

DOI: https://doi.org/10.1016/j.chom.2023.10.003

IF: 31.316

2023-01-01

Cell Host & Microbe

Abstract:Despite a wide presence of type III clustered regularly interspaced short palindromic repeats, CRISPR-associated (CRISPR-Cas) in archaea and bacteria, very few anti-CRISPR (Acr) proteins inhibiting type III immunity have been identified, and even less is known about their inhibition mechanism. Here, we present the discovery of a type III CRISPR-Cas inhibitor, AcrIIIB2, encoded by Sulfolobus virus S. islandicus rod-shaped virus 3 (SIRV3). AcrIIIB2 inhibits type III-B CRISPR-Cas immune response to protospacers encoded in middle/lateexpressed viral genes. Investigation of the interactions between S. islandicus type III-B CRISPR-Cas Cmra-related proteins and AcrIIIB2 reveals that the Acr does not bind to Csx1 but rather interacts with the Cmr-a effector complex. Furthermore, in vitro assays demonstrate that AcrIIIB2 can block the dissociation of cleaved target RNA from the Cmr-a complex, thereby inhibiting the Cmr-a turnover, thus preventing host cellular dormancy and further viral genome degradation by the type III-B CRISPR-Cas immunity.
Inhibition mechanisms of CRISPR-Cas9 by AcrIIA25.1 and AcrIIA32

DOI: https://doi.org/10.1007/s11427-024-2607-8

2024-06-07

Science China Life Sciences

Abstract:In the ongoing arms race between bacteria and bacteriophages, bacteriophages have evolved anti-CRISPR proteins to counteract bacterial CRISPR-Cas systems. Recently, AcrIIA25.1 and AcrIIA32 have been found to effectively inhibit the activity of SpyCas9 both in bacterial and human cells. However, their molecular mechanisms remain elusive. Here, we report the cryo-electron microscopy structures of ternary complexes formed by AcrIIA25.1 and AcrIIA32 bound to SpyCas9-sgRNA. Using structural analysis and biochemical experiments, we revealed that AcrIIA25.1 and AcrIIA32 recognize a novel, previously-unidentified anti-CRISPR binding site on SpyCas9. We found that both AcrIIA25.1 and AcrIIA32 directly interact with the WED domain, where they spatially obstruct conformational changes of the WED and PI domains, thereby inhibiting SpyCas9 from recognizing protospacer adjacent motif (PAM) and unwinding double-stranded DNA. In addition, they may inhibit nuclease activity by blocking the dynamic conformational changes of the SpyCas9 surveillance complex. In summary, our data elucidate the inhibition mechanisms of two new anti-CRISPR proteins, provide new strategies for the modulation of SpyCas9 activity, and expand our understanding of the diversity of anti-CRISPR protein inhibition mechanisms.

biology
Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins

Lingguang Yang,Yi Zhang,Peipei Yin,Yue Feng

DOI: https://doi.org/10.1080/15476286.2021.1985347

2021-10-04

RNA Biology

Abstract:Phage infection is one of the major threats to prokaryotic survival, and prokaryotes in turn have evolved multiple protection approaches to fight against this challenge. Various delicate mechanisms have been discovered from this eternal arms race, among which the CRISPR-Cas systems are the prokaryotic adaptive immune systems and phages evolve diverse anti-CRISPR (Acr) proteins to evade this immunity. Until now, about 90 families of Acr proteins have been identified, out of which 24 families were verified to fight against subtype I-F CRISPR-Cas systems. Here, we review the structural and biochemical mechanisms of the characterized type I-F Acr proteins, classify their inhibition mechanisms into two major groups and provide insights for future studies of other Acr proteins. Understanding Acr proteins in this context will lead to a variety of practical applications in genome editing and also provide exciting insights into the molecular arms race between prokaryotes and phages.

biochemistry & molecular biology

Structural basis of Cas3 inhibition by the bacteriophage protein AcrF3

Mechanistic insights into the inhibition of the CRISPR-Cas surveillance complex by anti-CRISPR protein AcrIF13

Structural and biochemical insights into the mechanism of the anti-CRISPR protein AcrIE3

Structural and Mechanistic Insight into CRISPR-Cas9 Inhibition by Anti-CRISPR Protein AcrIIC4Hpa

Mechanism of inhibition of CRISPR-Cas9 by anti-CRISPR protein AcrIIC1

Structural and mechanistic insights into inhibition of the type I-F CRISPR-Cas surveillance complex by AcrIF4

Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2

Inhibitory mechanism of CRISPR-Cas9 by AcrIIC4

AcrIIC4 inhibits type II-C Cas9 by preventing R-loop formation

Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein

Structural basis for inhibition of an archaeal CRISPR–Cas type I-D large subunit by an anti-CRISPR protein

Structural Basis for AcrVA4 Inhibition of Specific CRISPR-Cas12a

Anti-CRISPR Protein AcrIF4 Inhibits the Type I-F CRISPR-Cas Surveillance Complex by Blocking Nuclease Recruitment and DNA Cleavage

Cas9 Allosteric Inhibition by the Anti-CRISPR Protein AcrIIA6

Insights into the inhibition of type I-F CRISPR-Cas system by a multifunctional anti-CRISPR protein AcrIF24

Insights into the Dual Functions of AcrIF14 During the Inhibition of Type I-F CRISPR–Cas Surveillance Complex

Alternate binding modes of anti-CRISPR viral suppressors AcrF1/2 to Csy surveillance complex revealed by cryo-EM structures

Structural insight into multistage inhibition of CRISPR-Cas12a by AcrVA4

Molecular Basis for Inhibition of Type Iii-B Crispr-Cas by an Archaeal Viral Anti-Crispr Protein

Inhibition mechanisms of CRISPR-Cas9 by AcrIIA25.1 and AcrIIA32

Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins